Microsaic Systems Agreement with Rightek Co., Ltd.

Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments, has today announced that it has signed an agreement with Rightek Co., Ltd.

The Agreement covers the distribution of Microsaic’s 4500 MiD® mass spectrometry detector via Rightek’s distribution network in Taiwan.

Glenn Tracey, CEO of Microsaic, commented, “This agreement with Rightek further consolidates our strategy to extend the sales of our unique compact, point of need technology into the Asia Pacific area.

Rightek combines expertise in understanding end-user applications, together with a proven track record of working with a wide range of specialised scientific instrumentation.

This agreement is in line with our strategy to partner with locally based and established channel partners, with expertise in selling innovative analytical instrumentation to progressive end-users in process and pharmaceutical markets.”

Moses Shih, General Manager of Rightek, added “Rightek is committed to helping our customers achieve success, to solve their problems by finding suitable high-quality technologies to meet ever challenging demands. We believe that Microsaic’s compact, point-of-need systems can improve the efficiencies by optimizing the process in chemical and pharma industries.”

Microsaic Systems plc is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry (“MS”) instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

Established in December 2007, Rightek is headquartered in Wujin District, New Taipei City, and also has offices in Taichung and Kaohsiung. Rightek distributes a wide range of scientific equipment through its Analytical, Synthesis and Process Equipment divisions.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Microsaic Systems plc

    More articles like this

    Microsaic Systems plc

    VIDEO: Microsaic Systems Investor Presentation 2019

    Microsaic Systems (LON:MSYS) Investor Presentation by Glenn Tracey. Microsaic Systems plc is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry (“MS”) instruments that are designed to improve the efficiency of pharmaceutical R&D and

    Microsaic Systems plc

    Microsaic Systems plc Introduce New Protein Identification Product

    Glenn Tracey, CEO of Microsaic, commented, “Bringing the power of the centralised laboratory to in-situ bioprocessing line measurements, the Microsaic MiD® ProteinID reduces key bioprocessing analyses from days to minutes. This means that operators can monitor

    Microsaic Systems plc

    Advances in Analytics for Bioprocessing

    Richard Moseley, Chief Technologist at Microsaic talks to Biopharma International about process analytical technology (PAT) for monitoring and controlling biopharma production processes. When FDA’s process analytical technology (PAT) initiative was first unveiled, the aim was to

    Microsaic Systems plc

    The need for the miniaturisation of mass spectroscopy

    Microsaic Systems’ Chief Technologist, Richard Moseley, explains the need for miniaturised mass spectrometry, and where the technology can take some key industries such as pharma and biopharma. Arguably the work-horse of most analytical laboratories, mass spectrometry

    Microsaic Systems plc

    Encouraging efficiency

    Encouraging efficiency in pharmaceutical discovery and manufacturing, Microsaic’s Chief Technologist Dr. Richard Moseley discusses chip-based technologies and miniaturisation of mass spectrometry. The current challenges faced by the pharmaceutical industry are nothing new – high costs and

    Microsaic Systems plc

    Innovations in measurement, analysis and testing

    Richard Moseley, Chief Technologist at Microsaic Sytems PLC explains why accurate, timely and efficient measurement techniques are key to optimising production processes in pharmaceutical manufacturing and providing regulators with assurance on product quality. Specialist analytical chemists typically

    MySale Group Plc

    UK retail sees record online spending in 2018

    The latest UK retail report from the Office for National Statistics (ONS), revealed that in the three months to August, the quantity bought increased by 2 percent when compared with the previous three months, with continued

    Microsaic Systems plc

    INTERVIEW: Microsaic Systems 96% Increase in revenues

    Microsaic Systems Plc (LON:MSYS) CEO Glenn Tracey talks to DirectorsTalk about its unaudited interim results for the six months ended 30 June 2018. With a 96% increase in revenues and good operation progress Glenn provides us